Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DA6X
|
|||
| Former ID |
DIB009513
|
|||
| Drug Name |
JNJ-47910382
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 1 | [1] | |
| Company |
Janssen research & development
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01482611) A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382. U.S. National Institutesof Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.